The UK has granted Rs. 10 million in new funding to support vital immunology research between scientists at the MRC Weatherall Institute of Molecular Medicine, University of Oxford and the University of Sri Jayawardenepura who are studying the immune response of Covid-19 patients in different populations, UK High Commissioner Sarah Hulton said Friday(05).
Hulton lauded Sri Lanka’s participation in the Global Vaccine Summit where President Gotabaya Rajapaksa stressed the importance of sustaining vital immunization during pandemics.
She said the UK is committed to a fully coordinated international response to mitigate the global impact of COVID-19 and prevent a pandemic of this scale in the future. “We recognize the need to share lessons and work together, drawing on the best of global science and evidence.”
The UK hosted the Global Vaccine Summit on 4 June, bringing together leaders from around the world at a virtual event to pledge their support to Gavi, the Vaccine Alliance. The Global Vaccine Summit aimed to help Gavi save up to 8 million lives over the next five years and to protect 300 million more children against infectious diseases like measles.
The Global Vaccine Summit raised US$8.8 billion from 32 donor governments, 12 foundations, corporations and organisations, far exceeding the US$7.4 billion target.
Gavi is a crucial partner in the fight against infectious diseases globally, including coronavirus. With the support of UK aid, Gavi has immunized over 760 million children in the world’s poorest countries, saving more than 133 million lives.
Read more related news :-HavelockMagazine/Popular Stories